nu

Nestlé adjusts offering due to rise of weight-loss drugs

Nestlé adjusts offering due to rise of weight-loss drugs

Nestlé plans to develop new food products specifically designed for individuals using weight-loss medication. The company aims to address health challenges associated with rapid weight loss, such as muscle mass reduction, signaling a shift in how the food industry perceives these drugs.

Based on reporting by nu. Translated and condensed by LocalHeadlines.

Related articles

Jumbo recalls pulled chicken due to possible raw chicken content

Jumbo recalls pulled chicken due to possible raw chicken content

Jumbo is recalling its pulled chicken product because it may contain raw poultry, which carries a risk of salmonella or campylobacter infection. Customers can return the product to any Jumbo store for a full refund without needing a receipt.

From near extinction to a thriving fishery: how Portugal’s sardine population was saved

From near extinction to a thriving fishery: how Portugal’s sardine population was saved

After facing near-extinction due to overfishing, Portugal's sardine population is recovering thanks to a successful management plan. This restoration has revitalized the local fishing industry while ensuring the fish remains a sustainable and healthy staple of the Portuguese diet.

Vacancy | NU.nl is looking for a social economy and healthcare reporter

Vacancy | NU.nl is looking for a social economy and healthcare reporter

NU.nl is hiring a reporter specializing in social economy and healthcare to produce original, investigative stories for its audience. The full-time position requires three years of experience and is based in Amsterdam-Duivendrecht.

Criminals steal huge quantity of insulin pens from Novo Nordisk

Criminals steal huge quantity of insulin pens from Novo Nordisk

Novo Nordisk has reported the theft of a large quantity of insulin pens from a medical wholesaler, raising concerns about their illegal sale. The manufacturer warns that these stolen items could be falsely marketed as weight-loss drugs, posing life-threatening risks to non-diabetic users who might accidentally inject insulin.

Judge rejects request for investigation into Philips in sleep apnea affair

Judge rejects request for investigation into Philips in sleep apnea affair

The Dutch Enterprise Chamber has dismissed a request for an inquiry into Philips concerning the company's communication about a major sleep apnea device recall in 2021. The court ruled that there were no sufficient grounds to justify an investigation into the firm's disclosures to investors.